Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Deerfield Management Company, L.P.
Form 13F · Q2 2026

Deerfield Management Company, L.P.

CIK 1009258申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$95.9亿
申報組合市值
82
持倉數量
12
Quarters on record
Top 50
持倉數量

Deerfield Management Company, L.P.——持倉

共 82 個持倉中的前 50 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1NUVALENT INC Nuvalent Inc17.2M+0.0%$21.3亿22.2%
2RVMD Revolution Medicines Inc2.4M+4.1%$4.5亿4.7%
3PRAX Praxis Precision Medicines I963,351+0.0%$3.2亿3.4%
4VTRS Viatris Inc20.2M+0.0%$3.2亿3.3%
5CNC Centene Corp Del4.9M−17.2%$3.1亿3.3%
6UTHR United Therapeutics Corp Del457,000+0.0%$2.5亿2.6%
7LEGN Legend Biotech Corp8.1M+5.9%$2.4亿2.5%
8COGT Cogent Biosciences Inc5.0M−44.6%$1.9亿2.0%
9GMAB Genmab A/S6.9M+178.8%$1.9亿2.0%
10BKD Brookdale Sr Living Inc11.6M+0.0%$1.9亿2.0%
11VERA Vera Therapeutics Inc3.9M+5.2%$1.7亿1.8%
12IONS Ionis Pharmaceuticals Inc2.0M+0.0%$1.6亿1.6%
13CELC Celcuity Inc1.5M−15.3%$1.5亿1.6%
14BCRX Biocryst Pharmaceuticals Inc15.1M+0.4%$1.5亿1.6%
15NAMS Newamsterdam Pharma Company4.3M+0.0%$1.4亿1.5%
16ACHC Acadia Healthcare Company In4.5M+0.0%$1.3亿1.4%
17TNGX Tango Therapeutics Inc4.2M+1.1%$1.3亿1.4%
18AHCO Adapthealth Corp11.5M+0.0%$1.2亿1.2%
19PHVS Pharvaris N V3.4M+8.0%$1.2亿1.2%
20ARWR Arrowhead Pharmaceuticals In1.4M−11.7%$1.1亿1.2%
21DNTH Dianthus Therapeutics Inc1.1M+10.3%$1.1亿1.1%
22LRMR Larimar Therapeutics Inc35.6M+0.0%$1.1亿1.1%
23MLYS Mineralys Therapeutics Inc4.0M—$1.1亿1.1%
24IDYA Ideaya Biosciences Inc2.7M+77.4%$1.0亿1.1%
25XENE Xenon Pharmaceuticals Inc1.6M+0.0%$9752万1.0%
26SVRA Savara Inc13.6M+0.0%$8359万0.9%
27LNTH Lantheus Hldgs Inc752,999−9.1%$8354万0.9%
28SNDX Syndax Pharmaceuticals Inc3.8M+0.0%$8263万0.9%
29BMRN Biomarin Pharmaceutical Inc1.3M+56.5%$7626万0.8%
30PFE Pfizer Inc3.0M+0.0%$7320万0.8%
31INDIVIOR PHARMACEUTICALS INC Indivior Pharmaceuticals Inc1.6M−46.8%$6765万0.7%
32BIO Bio Rad Labs Inc226,070+0.0%$6638万0.7%
33SPRY Ars Pharmaceuticals Inc7.5M+0.0%$6011万0.6%
34STOK Stoke Therapeutics Inc1.8M+0.0%$5966万0.6%
35GPCR Structure Therapeutics Inc1.1M+41.4%$5829万0.6%
36NVST Envista Holdings Corporation2.2M+0.0%$5824万0.6%
37INSP Inspire Med Sys Inc1.3M−52.0%$5785万0.6%
38CDNA Caredx Inc2.0M−8.8%$5693万0.6%
39BSX Boston Scientific Corp1.3M—$5612万0.6%
40BLTE Belite Bio Inc357,199+17.5%$5500万0.6%
41PBLS Parabilis Medicines Inc1.9M—$5147万0.5%
42CERT Certara Inc7.5M−3.8%$4921万0.5%
43IRON Disc Medicine Inc657,000+0.0%$4805万0.5%
44BBOT Bridgebio Oncology Therapeut4.9M+0.0%$3723万0.4%
45TYRA Tyra Biosciences Inc1.0M+85.2%$3248万0.3%
46MNPR Monopar Therapeutics Inc323,745+0.0%$2998万0.3%
47SION Sionna Therapeutics Inc680,916−29.8%$2995万0.3%
48AVLN Avalyn Pharmaceuticals Inc731,000—$2406万0.3%
49FHTX Foghorn Therapeutics Inc4.4M+0.0%$2144万0.2%
50BBNX Beta Bionics Inc1.3M+0.0%$2075万0.2%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。